Publication | Open Access

Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals

Covid-19 InfectionAntiviral Drug DevelopmentAntiviral TherapyVirologyInfection ControlAntiviral DrugMedicineAntiviral CompoundEfficient TreatmentsCovid-19